Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sharon Glick

Pediatric Dermatology Brooklyn, NY Medical Doctor

NPI 1114911419 CMS profile 186848

450 Clarkson Ave, Suite H, Brooklyn, NY 11203

Open in the dashboard

General payments

$14,368

182 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,195 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Sharon Glick of Brooklyn, NY is reported in the CMS Open Payments database as having received $14,368 across 182 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,195 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 78th percentile of Pediatric Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,455 48
2024 General $1,394 40
2023 General $819 15
2022 General $386 6
2021 General $428 19
2020 General $1,987 24
2019 General $7,900 30

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sharon Glick
  • Pediatric Dermatology median
  • Middle half of Pediatric Dermatology
  • National median

In program year 2025, general payments to Sharon Glick were reported at $1,455. Among 172 Pediatric Dermatology profiles paid that year, the median was $302 and the middle half received between $110 and $2,128.

Show as a table
Year Sharon Glick Pediatric Dermatology median Middle half National median
2019 $7,900 $280 $89–$1,853 $163
2020 $1,987 $263 $71–$2,376 $114
2021 $428 $227 $69–$1,800 $132
2022 $386 $289 $69–$1,516 $149
2023 $819 $537 $114–$3,255 $160
2024 $1,394 $437 $114–$2,693 $164
2025 $1,455 $302 $110–$2,128 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pierre Fabre Pharmaceuticals, Inc. $7,159 3 payments
  2. Genzyme Corporation $1,837 15 payments
  3. Janssen Biotech, Inc. $866 29 payments
  4. Sun Pharmaceutical Industries Inc. $737 11 payments
  5. Pfizer Inc. $582 22 payments
  6. Janssen Scientific Affairs, LLC $313 3 payments
  7. Novartis Pharmaceuticals Corporation $291 11 payments
  8. AbbVie, Inc. $259 10 payments
  9. Incyte Corporation $257 4 payments
  10. Galderma Laboratories, L.P. $221 3 payments
  11. Other $1,847 71 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,683 177 payments
  2. Travel and Lodging $4,641 1 payment
  3. Honoraria $2,500 1 payment
  4. Consulting Fee $1,410 1 payment
  5. Education $135 2 payments
Products named General payments · program years 2019–2025
  1. DUPIXENT $1,895 17 payments
  2. TREMFYA $1,096 28 payments
  3. LITFULO $326 9 payments
  4. EUCRISA $309 15 payments
  5. CIBINQO $246 9 payments
  6. STELARA $240 13 payments
  7. Winlevi $157 2 payments
  8. VALCHLOR $146 6 payments
  9. VYJUVEK $132 8 payments
  10. SOTYKTU $129 4 payments
  11. Other $2,107 83 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

182 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record